Impact of Acute Kidney Injury on Long-Term Mortality after Nonmyeloablative Hematopoietic Cell Transplantation

Chirag Parikh, Sri G. Yarlagadda, Barry Storer, Mohamed Sorror, Rainer Storb, Brenda Sandmaier

Research output: Contribution to journalArticle

Abstract

Acute kidney injury (AKI) occurs frequently after nonmyeloablative hematopoietic cell transplantation (HCT). The severity of AKI after nonmyeloablative HCT has association with short-term mortality. However, the long-term effect of AKI on survival after nonmyeloablative HCT is not known. We performed a retrospective analysis of patients who underwent an HLA matched nonmyeloablative HCT between 1997 and 2006. Patients were followed for a median of 36 (range: 3-99) months. AKI occurring up to day 100 was defined as a >2-fold increase in serum creatinine or requirement of dialysis. Of the 358 patients who were included in the analysis, 200 (56%) had AKI, 158 (44%) had no AKI. Overall, 158 patients (43%) died during follow-up. After controlling for potential confounders, the adjusted hazard ratio for overall mortality associated with AKI was 1.57 (95 % confidence interval [CI] 1.2-2.3; P = .0006). The adjusted hazards ratio of nonrelapse mortality (NRM) associated with AKI was 1.72 (95% CI 0.9-3.1; P = .07). AKI is an independent predictor of overall mortality after nonmyeloablative HCT. This finding reiterates the importance of identifying preventative strategies in nonmyeloablative HCT for attenuating incidence and severity of AKI.

Original languageEnglish (US)
Pages (from-to)309-315
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume14
Issue number3
DOIs
StatePublished - Mar 1 2008

Fingerprint

Cell Transplantation
Acute Kidney Injury
Mortality
Confidence Intervals
Dialysis
Creatinine
Survival
Incidence

Keywords

  • Acute kidney injury
  • Bone marrow transplant
  • Prognosis
  • Renal dysfunction

ASJC Scopus subject areas

  • Transplantation

Cite this

Impact of Acute Kidney Injury on Long-Term Mortality after Nonmyeloablative Hematopoietic Cell Transplantation. / Parikh, Chirag; Yarlagadda, Sri G.; Storer, Barry; Sorror, Mohamed; Storb, Rainer; Sandmaier, Brenda.

In: Biology of Blood and Marrow Transplantation, Vol. 14, No. 3, 01.03.2008, p. 309-315.

Research output: Contribution to journalArticle

Parikh, Chirag ; Yarlagadda, Sri G. ; Storer, Barry ; Sorror, Mohamed ; Storb, Rainer ; Sandmaier, Brenda. / Impact of Acute Kidney Injury on Long-Term Mortality after Nonmyeloablative Hematopoietic Cell Transplantation. In: Biology of Blood and Marrow Transplantation. 2008 ; Vol. 14, No. 3. pp. 309-315.
@article{0d69776285c64c17adc6032b2b20d9ef,
title = "Impact of Acute Kidney Injury on Long-Term Mortality after Nonmyeloablative Hematopoietic Cell Transplantation",
abstract = "Acute kidney injury (AKI) occurs frequently after nonmyeloablative hematopoietic cell transplantation (HCT). The severity of AKI after nonmyeloablative HCT has association with short-term mortality. However, the long-term effect of AKI on survival after nonmyeloablative HCT is not known. We performed a retrospective analysis of patients who underwent an HLA matched nonmyeloablative HCT between 1997 and 2006. Patients were followed for a median of 36 (range: 3-99) months. AKI occurring up to day 100 was defined as a >2-fold increase in serum creatinine or requirement of dialysis. Of the 358 patients who were included in the analysis, 200 (56{\%}) had AKI, 158 (44{\%}) had no AKI. Overall, 158 patients (43{\%}) died during follow-up. After controlling for potential confounders, the adjusted hazard ratio for overall mortality associated with AKI was 1.57 (95 {\%} confidence interval [CI] 1.2-2.3; P = .0006). The adjusted hazards ratio of nonrelapse mortality (NRM) associated with AKI was 1.72 (95{\%} CI 0.9-3.1; P = .07). AKI is an independent predictor of overall mortality after nonmyeloablative HCT. This finding reiterates the importance of identifying preventative strategies in nonmyeloablative HCT for attenuating incidence and severity of AKI.",
keywords = "Acute kidney injury, Bone marrow transplant, Prognosis, Renal dysfunction",
author = "Chirag Parikh and Yarlagadda, {Sri G.} and Barry Storer and Mohamed Sorror and Rainer Storb and Brenda Sandmaier",
year = "2008",
month = "3",
day = "1",
doi = "10.1016/j.bbmt.2007.12.492",
language = "English (US)",
volume = "14",
pages = "309--315",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Impact of Acute Kidney Injury on Long-Term Mortality after Nonmyeloablative Hematopoietic Cell Transplantation

AU - Parikh, Chirag

AU - Yarlagadda, Sri G.

AU - Storer, Barry

AU - Sorror, Mohamed

AU - Storb, Rainer

AU - Sandmaier, Brenda

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Acute kidney injury (AKI) occurs frequently after nonmyeloablative hematopoietic cell transplantation (HCT). The severity of AKI after nonmyeloablative HCT has association with short-term mortality. However, the long-term effect of AKI on survival after nonmyeloablative HCT is not known. We performed a retrospective analysis of patients who underwent an HLA matched nonmyeloablative HCT between 1997 and 2006. Patients were followed for a median of 36 (range: 3-99) months. AKI occurring up to day 100 was defined as a >2-fold increase in serum creatinine or requirement of dialysis. Of the 358 patients who were included in the analysis, 200 (56%) had AKI, 158 (44%) had no AKI. Overall, 158 patients (43%) died during follow-up. After controlling for potential confounders, the adjusted hazard ratio for overall mortality associated with AKI was 1.57 (95 % confidence interval [CI] 1.2-2.3; P = .0006). The adjusted hazards ratio of nonrelapse mortality (NRM) associated with AKI was 1.72 (95% CI 0.9-3.1; P = .07). AKI is an independent predictor of overall mortality after nonmyeloablative HCT. This finding reiterates the importance of identifying preventative strategies in nonmyeloablative HCT for attenuating incidence and severity of AKI.

AB - Acute kidney injury (AKI) occurs frequently after nonmyeloablative hematopoietic cell transplantation (HCT). The severity of AKI after nonmyeloablative HCT has association with short-term mortality. However, the long-term effect of AKI on survival after nonmyeloablative HCT is not known. We performed a retrospective analysis of patients who underwent an HLA matched nonmyeloablative HCT between 1997 and 2006. Patients were followed for a median of 36 (range: 3-99) months. AKI occurring up to day 100 was defined as a >2-fold increase in serum creatinine or requirement of dialysis. Of the 358 patients who were included in the analysis, 200 (56%) had AKI, 158 (44%) had no AKI. Overall, 158 patients (43%) died during follow-up. After controlling for potential confounders, the adjusted hazard ratio for overall mortality associated with AKI was 1.57 (95 % confidence interval [CI] 1.2-2.3; P = .0006). The adjusted hazards ratio of nonrelapse mortality (NRM) associated with AKI was 1.72 (95% CI 0.9-3.1; P = .07). AKI is an independent predictor of overall mortality after nonmyeloablative HCT. This finding reiterates the importance of identifying preventative strategies in nonmyeloablative HCT for attenuating incidence and severity of AKI.

KW - Acute kidney injury

KW - Bone marrow transplant

KW - Prognosis

KW - Renal dysfunction

UR - http://www.scopus.com/inward/record.url?scp=38949161079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949161079&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2007.12.492

DO - 10.1016/j.bbmt.2007.12.492

M3 - Article

C2 - 18275897

AN - SCOPUS:38949161079

VL - 14

SP - 309

EP - 315

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 3

ER -